Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease.

@article{Kawanaka2015CorrelationBS,
  title={Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease.},
  author={Miwa Kawanaka and Ken Nishino and Jun - Ichi Sagara Shugo Nakamura and Noriyo Urata and Takahito Oka and Daisuke Goto and Mitsuhiko Suehiro and Hirofumi Kawamoto and Gotaro Yamada},
  journal={Annals of hepatology},
  year={2015},
  volume={14 6},
  pages={837-44}
}
BACKGROUND Diagnosis of non-alcoholic fatty liver disease (NAFLD) is limited by the need for liver biopsies. Serum cytokeratin 18 (CK-18) levels have been investigated as potential biomarkers for the presence of NAFLD and non-alcoholic steatohepatitis (NASH). Herein, we assessed the correlation between CK-18 levels and NAFLD progression. MATERIAL AND METHODS Serum CK-18 levels were estimated using the M30 antibody enzyme-linked immunosorbent assay in 147 patients diagnosed with NAFLD. In 72… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Usefulness of monitoring serum cytokeratin-18 levels for evaluating long-term prognosis is patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease [Abstract

M Kawanaka, K Nishino, +4 authors M Suehiro
Hepatology • 2013
View 6 Excerpts
Highly Influenced

Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2008
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…